The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia - Wikidata - awgldk - TriplyDB

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q57374971

about

Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids ZAP-70 in B cell malignancies Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemia Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.Genomic data integration in chronic lymphocytic leukemia.SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL.Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival.Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks.Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia.ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis.Human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients.How I treat CLL up front.Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression The use of microarray technologies in clinical oncology The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.Expression and role of RIP140/NRIP1 in chronic lymphocytic leukemia.Characterization of autosomal copy-number variation in African Americans: the HyperGEN Study.Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells.Developing Molecular Signatures for Chronic Lymphocytic Leukemia.Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia.Identification and validation of biomarkers of IgV(H) mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology.Lipoprotein lipase is frequently overexpressed or translocated in cervical squamous cell carcinoma and promotes invasiveness through the non-catalytic C terminus.New molecular markers in resistant B-CLL.CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.Metabolism pathways in chronic lymphocytic leukemia.Lipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemia Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia.Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia.RNA-based markers as prognostic factors in chronic lymphocytic leukemia.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.Search for an aetiological virus candidate in chronic lymphocytic leukaemia by extensive transcriptome analysis.Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients.Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment.

P2860

Q26996516-1E9AA6C5-7989-44E8-9A87-A7F5B6176FFC Q28279902-C6537C85-0D3E-447C-9B66-9342C4629DCA Q28282822-8FB41B72-D1D8-4B43-A075-BB2E8103754E Q30248557-FE1415A5-F2ED-400D-9D53-0C2616A9C232 Q31147488-1055F943-82FF-44DA-8B4D-53EC081CA4BA Q33330596-29808D3C-C30A-4DCE-AAC8-ADC004A3B6B2 Q33587644-BB76B9C8-8FF8-4C46-875E-972076DE5358 Q33813862-8B1D8904-918A-4B0C-B60F-FD3A550A97F1 Q33862792-867E3680-506B-4A73-9E45-B69C9F5BF64B Q33886052-E67767E9-B6D9-4571-BA95-33FFA09FE8AD Q34049378-CAFB6288-BF85-4A55-BF0C-F66324739A6D Q34091109-3579D3D4-2EBE-41C4-8118-18A7C7D7F9AB Q34137158-B1AEEEED-C341-4EB1-BA56-A899BEA19567 Q34253142-FAF8BD3F-57CF-4CFA-9FF7-E65D6267053E Q34496896-7DE062AE-759E-42E1-AAB9-2AE34C72B407 Q34542102-C2CA6480-2A83-4009-A4B1-6F456D37AF5D Q35143479-CC0E94E3-6F34-4258-9488-4B66707D8847 Q35162589-E07BFE4E-3E17-44B3-BBFA-AE1EA34F29C8 Q35591673-124578F3-6504-4B3D-BA54-C740D46A00C5 Q35611369-0806F1E9-BF20-4DB5-B331-84DD66B60D21 Q35653850-BB480CA8-2B13-4437-9B01-BC09F1B2E220 Q35852820-E050B3DD-24E5-474C-8FB7-7E095F66AC1A Q35988140-E4885DAC-8CB5-40EF-AC3A-6F7E25CD7608 Q36166804-3541975B-FB6F-4448-8A52-6161E8B91982 Q36497411-CBB91CCF-0D02-46C8-8349-CEC1CD408A19 Q36579130-B731EB69-C794-4C9D-88A1-0A3444084055 Q36693111-337AE4D5-034D-4540-9222-3A229363ECD3 Q36942667-C2F4DFCF-3AD5-4C98-B8AF-228AA76CF6BB Q37082690-B3C61AAC-0DEC-4D1D-8BF2-5DBEC846382A Q37340635-108AE426-AA49-4B2B-AB52-4D10C9D63E2A Q37552790-90809946-A2F2-43AA-80D7-E364BD56D465 Q37978344-F390C7E3-5DCA-4E2D-8C5D-472230CD9F19 Q38088354-2A7A6744-E908-411A-905A-A9B546C977CF Q38511275-60732EF5-AF51-42B8-8CD7-6B62B5A78E56 Q38722530-FB80CDDB-1989-4506-B68D-0F9C2E64B384 Q39273067-1F237396-8444-4B8D-AD58-09BC26C879AC Q39512567-E614E746-5B1C-42CB-83E0-88DC6160C9B8 Q40029728-98AF1FEF-3F59-4008-84B3-ADF7E74D1F07 Q40138593-175419B0-02D1-4DA9-99BC-4B5C6A4103A9 Q45384341-BE8A7B4E-F6AD-4A72-A2BE-088A66884BE1

P2860

The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q57374971

description

im Juli 2005 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 31 March 2005

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2005

@uk

name

The LPL/ADAM29 expression rati ...... n chronic lymphocytic leukemia

@en

The LPL/ADAM29 expression rati ...... n chronic lymphocytic leukemia

@nl

type

label

The LPL/ADAM29 expression rati ...... n chronic lymphocytic leukemia

@en

The LPL/ADAM29 expression rati ...... n chronic lymphocytic leukemia

@nl

prefLabel

The LPL/ADAM29 expression rati ...... n chronic lymphocytic leukemia

@en

The LPL/ADAM29 expression rati ...... n chronic lymphocytic leukemia

@nl

P1433

Q57374971-97455772-0010-4D34-9008-70B8EF940647

P1476

Q57374971-AAE21510-B7CE-4455-800B-532D2B4B7FDF

P2093

Q57374971-0A68DD5C-5515-4F26-8E11-157564FEB77A

Q57374971-15D3DCEF-2017-4FE5-BF2F-EA412136556C

Q57374971-19955459-9CAB-4A1A-A3F6-58D3B49B4029

Q57374971-38F114CF-6257-460A-9E23-E2E50BF82BB2

Q57374971-4ECE20CC-2992-489C-92A9-D0400D0F380A

Q57374971-56BA39F1-7A56-43A1-AB44-3499547DDD02

Q57374971-5F86617E-78C1-494F-B4F9-A7930E9C550A

Q57374971-992B449A-A8DC-4292-97CE-CCF24ADC13E2

Q57374971-A0BF17E5-2559-4FA7-B1D9-FB20EC00AF96

Q57374971-D8BE64B9-D043-4B64-A100-D350400611F6

P304

Q57374971-8DB79D75-6739-4CE9-B822-C69541A7E46B

P31

Q57374971-30DDCFA5-22AC-41F0-B27E-9E3AD286F182

P356

Q57374971-14629C90-C979-4877-B949-7714E20E200A

P407

Q57374971-B63EECF3-6209-4BCB-88D3-30CE7464DDEB

P433

Q57374971-1AB4D7E7-E22C-4AD8-B1C9-3994C560AC49

P478

Q57374971-5624394D-9D6E-422F-B247-0D2224B95F69

P50

Q57374971-145C2F87-E9E7-4E0B-A5B1-8E584F3BDC9E

Q57374971-9869ED6B-3841-40BA-873D-7E1FADA0788B

Q57374971-EE223351-9553-4B37-9D2C-C9993DBF2240

P577

Q57374971-64DDA4CB-EAAC-4702-8D7E-5A1419AF5175

P698

Q57374971-1331052B-8ECC-4E53-B708-1D7F7BC7EA7F

P921

Q57374971-3A8579CF-000C-40CB-9A02-1DF61245E0D1

P356

BLOOD-2004-08-3344

P1433

P1476

The LPL/ADAM29 expression rati ...... n chronic lymphocytic leukemia

@en

P2093

Catherine Settegrana

http://www.w3.org/2001/XMLSchema#string

Dominique Jeannel

http://www.w3.org/2001/XMLSchema#string

Eliza Yuriko Kimura

http://www.w3.org/2001/XMLSchema#string

Françoise Vuillier

http://www.w3.org/2001/XMLSchema#string

French Cooperative Group on CLL

http://www.w3.org/2001/XMLSchema#string

Frédéric Davi

http://www.w3.org/2001/XMLSchema#string

Guillaume Dighiero

http://www.w3.org/2001/XMLSchema#string

Gérard Dumas

http://www.w3.org/2001/XMLSchema#string

Martine Brissard

http://www.w3.org/2001/XMLSchema#string

Mihoko Yamamoto

http://www.w3.org/2001/XMLSchema#string

P304

650-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2004-08-3344

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Hélène Merle-Béral

Magali Le Garff-Tavernier

P577

2005-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15802535

http://www.w3.org/2001/XMLSchema#string

P921